This study is in progress, not accepting new patients
Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Alain Algazi
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Alain Algazi
Associate Professor, Medicine. Authored (or co-authored) 60 research publications.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Bristol-Myers Squibb
- Links
- BMS Clinical Trial Information BMS Clinical Trial Patient Recruiting FDA Safety Alerts and Recalls
- ID
- NCT02823574
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated